ACADIA PHARMACEUTICALS INC (ACAD) › RevenueACADIA PHARMACEUTICALS INC (ACAD) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $17.33M2017: $124.90M2018: $223.81M2019: $339.08M2020: $441.75M2021: $484.14M2022: $517.24M2023: $726.44M2024: $957.80M2025: $1.07B$1.07B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$1.07B+11.9%2024$957.80M+31.8%2023$726.44M+40.4%2022$517.24M+6.8%2021$484.14M+9.6%2020$441.75M+30.3%2019$339.08M+51.5%2018$223.81M+79.2%2017$124.90M+620.7%2016$17.33M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share